Studying at the University of Verona

Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.

Study Plan

This information is intended exclusively for students already enrolled in this course.
If you are a new student interested in enrolling, you can find information about the course of study on the course page:

Combined Bachelor's + Master's degree in Pharmacy - Enrollment from 2026/2027

The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.

2° Year  activated in the A.Y. 2024/2025

ModulesCreditsTAFSSD
3
F
INF/01
English B2
6
E
-

5° Year  It will be activated in the A.Y. 2027/2028

ModulesCreditsTAFSSD
Final exam
18
E
-
activated in the A.Y. 2024/2025
ModulesCreditsTAFSSD
3
F
INF/01
English B2
6
E
-
It will be activated in the A.Y. 2027/2028
ModulesCreditsTAFSSD
Final exam
18
E
-
Modules Credits TAF SSD
Between the years: 1°- 2°- 3°- 4°- 5°

Legend | Type of training activity (TTA)

TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.




S Placements in companies, public or private institutions and professional associations

Teaching code

4S000070

Credits

9

Coordinator

Gianluca Trifiro'

Language

Italian

Courses Single

Not Authorized

The teaching is organized as follows:

CHEMIOTERAPIA

Credits

3

Period

Secondo semestre 2026/2027

Academic staff

Marco Tuccori

Learning objectives

The educational objectives of the course are the learning of knowledge in the field of Clinical Pharmacology as it is implemented in the complexity and variability of the different clinical conditions, chronicity and personalization in the field of pharmacotherapy and chemotherapy. The student will learn:
• factors and clinical conditions influencing biotransformation: age; pregnancy; race (polymorphism); diet; pathologies; sex; route of drug administration; drug induction and inhibition of metabolism.
• factors and clinical conditions influencing renal clearance and hepatic function
• Factors linked to the genetic component
• Pharmacogenetics;
• Polypharmacy;
• the variability of the pharmacological response: individual, hyperreactivity and hyporeactivity, idiosyncrasy, drug allergy, tolerance, dependence.
• In-depth study of clinical trials to learn about the drug development phases with particular reference to the rules of randomized controlled trials necessary for an evidence-based therapeutic approach and to know how to critically read the experimental design and the results of a clinical trial and post- marketing.

Prerequisites and basic notions

Knowledge of the principles of general pharmacology and the main characteristics of pharmacology of main drug classes

Learning assessment procedures

Written and oral exam on the complete program.
The written test to ascertain knowledge consists of 30 questions, with multiple answers of which only one is correct, and - if the sufficiency of 18/30 is reached. - from 2) an oral interview to ascertain the critical knowledge for the possible improvement of the mark. For those who pass the written test, the oral test is optional.

Students with disabilities or specific learning disorders (SLD), who intend to request the adaptation of the exam, must follow the instructions given HERE

Evaluation criteria

The exam will verify the acquisition of knowledge relating to clinical pharmacological research, the therapeutic properties of drugs, possible adverse reactions and the factors that influence the variability and personalization of the response in clinical use

The grade is out of thirty: maximum score is 30/30.

Criteria for the composition of the final grade

Oral exam with questions on clinical pharmacology and chemotherapy